Michael Landsittel - May 8, 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Melissa Masse, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
May 8, 2024
Transactions value $
$65,297
Form type
4
Date filed
5/10/2024, 04:05 PM
Previous filing
May 6, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $49.3K +26.4K +55.75% $1.87* 73.6K May 8, 2024 Direct F1
transaction BPMC Common Stock Options Exercise $16K +1.82K +2.47% $8.80* 75.5K May 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 +26.4K $0.00* 0 May 8, 2024 Common Stock 26.4K $1.87 Direct F2
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 +1.82K $0.00* 0 May 8, 2024 Common Stock 1.82K $8.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a cash exercise of options without a subsequent sale of the underlying shares of common stock.
F2 The options were granted on February 10, 2015 and are fully vested as of the transaction date.
F3 The options were granted on October 8, 2014 and are fully vested as of the transaction date.